首页> Nature medicine> Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial.

Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial.

导出 OA

翻译打印收藏纠错

第一作者： Thomas,Powles

第一单位： Barts Cancer Institute, Queen Mary University of London, London, UK. thomas.powles1@nhs.net.

作者： Thomas,Powles ^[1] ; Kobe C,Yuen ^[2] ; Silke,Gillessen ^[3] ; Edward E,Kadel ^[2] ; Dana,Rathkopf ^[4] ; Nobuaki,Matsubara ^[5] ; Charles G,Drake ^[6] ; Karim,Fizazi ^[7] ; Josep M,Piulats ^[8] ; Piotr J,Wysocki ^[9] ; Gary L,Buchschacher ^[10] ; Boris,Alekseev ^[11] ; Begoña,Mellado ^[12] ; Bogusława,Karaszewska ^[13] ; Jennifer F,Doss ^[14] ; Grozdana,Rasuo ^[15] ; Asim,Datye ^[15] ; Sanjeev,Mariathasan ^[2] ; Patrick,Williams ^[2] ; Christopher J,Sweeney ^[16]

作者单位： Barts Cancer Institute, Queen Mary University of London, London, UK. thomas.powles1@nhs.net. ^[1] Genentech, Inc., South San Francisco, CA, USA. ^[2] Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.;Faculty of Biomedical Sciences, Universita della Svizzera Italiana, Lugano, Switzerland. ^[3] Memorial Sloan Kettering Cancer Center, New York, NY, USA. ^[4] National Cancer Center Hospital East, Chiba, Japan. ^[5] Columbia University Irving Medical Center, New York, NY, USA. ^[6] Gustave Roussy, University of Paris Saclay, Villejuif, France. ^[7] Institut Català d'Oncologia-IDIBELL-CIBERONC, Barcelona, Spain. ^[8] Jagiellonian University Medical College, Krakow, Poland. ^[9] Kaiser Permanente Southern California, Los Angeles Medical Center, Los Angeles, CA, USA. ^[10] Research Oncology Institute, Tomsk, Russia. ^[11] Medical Oncology Department, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Hospital Clínic i Provincial, Barcelona, University of Barcelona, Barcelona, Spain. ^[12] Przychodnia Lekarska KOMED, Konin, Poland. ^[13] Genentech, Inc., South San Francisco, CA, USA.;Global Blood Therapeutics, Inc., South San Francisco, CA, USA. ^[14] F. Hoffmann-La Roche Ltd, Basel, Switzerland. ^[15] Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Christopher_Sweeney@dfci.harvard.edu. ^[16]